Utility of 18F-FDG PET-CT in staging and restaging of patients with malignant salivary gland tumours

Adult Male Submandibular Gland Middle Aged Salivary Gland Neoplasms Multimodal Imaging 3. Good health Sublingual Gland 03 medical and health sciences 0302 clinical medicine Fluorodeoxyglucose F18 Positron-Emission Tomography Image Processing, Computer-Assisted Humans Parotid Gland Female Radiopharmaceuticals Tomography, X-Ray Computed Aged Neoplasm Staging Retrospective Studies Ultrasonography
DOI: 10.1097/mnm.0b013e32835bc4c4 Publication Date: 2012-12-12T07:53:41Z
ABSTRACT
The aim of this study was to evaluate the clinical utility (18)F-fluorodeoxyglucose ((18)F-FDG) positron emission tomography-computed tomography (PET-CT) in staging and restaging patients with malignant primary salivary gland tumours.Data pertaining 30 (age: 43.8±16.8 years; male/female: 20/10) histopathologically proven tumours who underwent 36 F-FDG PET-CTs were retrospectively analysed. Ten performed for 26 restaging. site parotid 22 patients, submandibular seven minor one patient. (18)F-FDG PET-CT images revaluated by two nuclear medicine physicians consensus. Findings grouped into local disease, nodal disease distant metastasis. Results compared those conventional imaging modalities [CIM (CT/ultrasound/bone scintigraphy)] when available (n=28). Clinical or follow-up (minimum 6 months) data along histopathological information (when available) taken as reference standard.Overall, 25 positive 11 negative disease. showed 21 17 metastasis nine (lungs, four; liver, three; bones, thyroid, one). Twenty-three true positive, negative, false negative. overall sensitivity 92%, specificity 82%, predictive value 82% accuracy 89%. No significant difference seen between groups (100 vs. 85%; P=0.468). In whom comparable CIM (n=28), did not show any advantage over (P=0.012) but more specific (71 43%).(18)F-FDG shows high tumours. It is than purpose.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (18)
CITATIONS (30)